Products (AnaConDa-S)


Operating Conditions

Description
Disposable product: Single patient, 24 hours use
Anaesthetic agents: Isoflurane or Sevoflurane
Efficiency: Normally > 88% is reflected.
Depending on Minute Volume
Dosing: Depending on clinical needs.
(See Table 1a)
Tidal volume working range: Minimum 200 ml
Resistance to gas flow @ 60 L/min: 3.5 cm H2O (350 Pa)
Moisture loss at 0.75 l x 12 breaths/min: 5 mg/l
Corresponding moisture output: 30 mg H2O/l
Moisture loss at 1.0 l x 10 breaths/min: 6 mg/l
Corresponding moisture output: 29 mg H2O/l
Bacterial filtration: 99.999%
Viral filtration: 99.98%
Dead space: Approx. 50 ml
Connectors: 15M/22M-15F
Weight: 38 g
Gas sampling port: Female luer lock
Agent supply line: 2200 mm

AnaConDa-S

Ref: 26050


Product Description

AnaConDa is a disposable medical device which allows the administration of volatile anaesthetics (Isoflurane or Sevoflurane) and is connected between the Y-piece and ET-tube. The device has no electrical components and is MRI & CT scan compatible. It also acts as an excellent HME and contains a bacterial/viral filter. This version has a lower dead space of 50ml and can function with tidal volumes as low as 200ml.

  • Reference Number: 26050
  • Use: Single Patient, 24 hour use
  • Device Classification: Class IIa
  • Shelf Life: 5 Years from Date of Manufacturing
  • Disposal: Normal hospital waste
  • Minimum Order Quantity: 12 Units

Dosage

Dosing is based on individual patient clinical requirements and is guided by clinical evaluation and reading of the Fet/MAC value on the gas monitor. The syringe pump rate is determined by the minute volume, end tidal concentration (Fet) or MAC requirements and the clinical needs of the patient. The following syringe pump rates are typical for Isoflurane or Sevoflurane.

Table 1a

Volatile
Agent
Expected
Pump Rates
Resulting
Fet Values
Isoflurane 2-7 ml/hr 0,2-0,7 %
Sevoflurane 4-10 ml/hr 0,5-1,4 %

This table gives is an approximate pump rate and concentration guide, other pump rates and concentrations can be achieved depending on clinical needs.

(Induction Phase) of administration. Adjustments to the pump rate will need to be made according to the measured end tidal concentration (Fet) or MAC and the clinical needs of the patient.

Please refer to “Instructions for Use” for more information.